Grasp the latest information from Olin and understand the new trends in the industry.
On March 26, 2026, Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”, Stock Code: 688319) and Westlake University officially signed a cooperation agreement. Following multiple on-site inspections and in-
Recently, the China National Intellectual Property Administration issued the Notice on Determining the Demonstration Creation Objects for the Construction of a National Intellectual Property Powerhouse (2025-2027). Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”) was successfully selected as a “National Intellectual Property Demonstration Enterprise Creation Object” by virtue of its systematic layout and outstanding achievements in the comprehensive management of in
On December 11, 2025, Mr. Matthew Fosbery, Deputy Commercial Consul of Australia in Chengdu and Trade & Investment Commissioner of Austrade, and Ms. Wang Ming, Commercial Officer of Austrade, visited Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”, stock code: 688319) for inspection and exchanges, and had in-
Recently, the results of the “High-Integrity Enterprises” Selection and Publicity Campaign in Sichuan Province were announced, which was jointly organized by 25 departments such as Sichuan Provincial Development and Reform Commission, Cyberspace Administration Office of Sichuan Provincial Party Committee, and State-owned Assets Supervision and Administration Commission of Sichuan Province. Chengdu Olymvax Biopharmaceuticals Inc.
In the afternoon of August 25, 2021, Wang Yihong, Deputy Director of the NPC Standing Committee of Sichuan Province and Secretary General of the CPC Committee of Sichuan Province, and his delegation conducted an in-depth investigation on some listed and possibly listed pharmaceutical enterprises in Chengdu. Chengdu Olymvax Biopharmaceuticals Inc.
On June 8, Chengdu Olymvax Biopharmaceuticals Inc. was successfully listed on the Science and Technology Venture Board of Shanghai Stock Exchange. OLYMVAX (688319.SH) issued 40,530,000 shares at a price of RMB 9.88 per share, raising a total of RMB 400,436,400, with a total share capital of 405,265,000 shares after the issuance.
The Spring Festival of 2021 was destined to be an extraordinary Spring Festival. In the context of the resurgence of COVID-19, in order to stabilize the development of all enterprises, promote them to get off to a good start in 2021, and let the employees of all enterprises spend the New Year in Chengdu with peace of mind, Vice Director Zeng Ke and his delegation, along with five companies in the biological industry and the Association of Experts in Chengdu High Tech Bio-industry, held a special
He once led Sichuan Shuyang to become a leading enterprise in the blood product industry, led Zhongyuan Ruide from loss to profit in just three years to realize consecutive sales growth, and also revitalized Guiyang Qianfeng Bio-Products, then merged it into Taibang Biologic Group, and successfully entered the overseas capital market...In the more than 40 years of work, Fan Shaowen, a maker in Chengdu High-tech Zone, has repeatedly performed the “Midas Touch” to make many biological products ent